Sphingolipids: Their role in intracellular signaling and renal growth

Journal of the American Society of Nephrology

Volumn 7, Issue 2, 1996, Pages 171-182

  Shayman, James A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ceramide; Diabetes mellitus; Kidney; Polycystic kidney disease; Sphingolipids

Indexed keywords

CERAMIDE; SPHINGOLIPID;

APOPTOSIS; CELL GROWTH; DIABETES MELLITUS; HUMAN; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL PROCESSING;

EID: 0029927759     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v72171     Document Type: Review

References (106)

1. Takai Y, Kishimoto A, Iwasa Y, Kawahara Y, Mori T, Nishizuka Y: Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem 1979;254:3692-3695.
2. Shayman JA, Radin NS: Structure and function of renal glycosphingolipids. Am J Physiol 1991;260:(Renal Fluid Electrolyte Physiol 29):F291-F302.
3. Radin NS: Biosynthesis of the sphingoid bases: A provocation. J Lipid Res 1984;25:1536-1540.
4. Merrill AH Jr, Jones DD: An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta 1990;1044:1-12.
5. Karlsson KA: On the chemistry and occurrence of sphingolipid long-chain bases. Chem Phys Lipids 1970; 5:6-43.
6. 20-dihydrosphingosines, ketodihydrosphingosines, and ceramides by microsomal preparations from mouse brain. J Biol Chem 1970;245:335-341.
7. Igarashi Y, Kitamura K, Toyokuni T, et al.: A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation. J Biol Chem 1990;265:5385-5389.
8. Yamaguchi Y, Sasagasako N, Goto I, Kobayashi T: The synthetic pathway for glucosylsphingosine in cultured fibroblasts. J Biochem (Tokyo) 1994;116:704-710.
9. Barenholz Y, Thompson TE: Sphingomyelins in bilayers and biological membranes. Biochim Biophys Acta 1980;604:129-158.
10. Cohen R, Barenholz Y: Correlation between the thermotropic behavior of sphingomyelin liposomes and sphingomyelin hydrolysis by sphingomyelinase of Staphylococcus aureus. Biochim Biophys Acta 1978; 509:181-187.
11. Chang Y, Abe A, Shayman JA: Ceramide formation during heat shock: a potenial mediator of αB-crystallin transcription. Proc Natl Acad Sci USA 1995;92:12275-12279.
12. Abe A, Wu D, Shayman JA, Radin NS: Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C. Eur J Biochem 1992;210:765-773.
13. Sundaram KS, Lev M: Inhibition of sphingolipid synthesis by cycloserine in vitro and in vivo. J Neurochem 1984;42:577-581.
14. Medlock KA, Merrill AH Jr: Inhibition of serine palmityltransferase in vitro and long-chain base biosynthesis in intact Chinese hamster ovary cells by β-chloroalanine. Biochemistry 1988;27:7079-7084.
15. Norred WP, Wang E, Yoo H, Riley RT, Merrill AH Jr: In vitro toxicology of fumonisins and the mechanistic implications. Mycopathologia 1992;117:73-78.
16. Mahdiyoun S, Deshmukh GD, Abe A, Radin NS, Shayman JA: Decreased formation of inositol triphosphate in Madin-Darby canine kidney cells under conditions of β-glucosidase inhibition. Arch Biochem Biophys 1992; 292:506-511.
17. Radin NS, Shayman JA, Inokuchi J: Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv Lipid Res 1993;26:183-213.
18. Abe A, Inokuchi J, Jimbo M, et al.: Improved inhibitors of glucosylceramide synthase. J Biochem (Tokyo) 1992; 111:191-196.
19. Abe A, Radin NS, Shayman JA, et al.: Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J Lipid Res 1995;36:611-621.
20. Ferlinz K, Hurwitz R, Vielhaber G, Suzuki K, Sandhoff K: Occurrence of two molecular forms of human acid sphingomyelinase. Biochem J 1994;301:855-862.
21. Schulte S, Stoffel W: Ceramide UDPgalactosyltransferase from myelinating rat brain: Purification, cloning, and expression. Proc Natl Acad Sci U S A 1993;90: 10265-10269.
22. Nagiec MM, Baltisberger JA, Wells GB, Lester RL, Dickson RC: The LCB2 gene of Saccharomyces and the related LCB1 gene encode subunits of serine palmityltransferase, the initial enzyme in sphingolipid synthesis. Proc Natl Acad Sci U S A 1994;91:7899-7902.
23. Doll RF, Smith FI: Regulation of expression of the gene encoding human acid beta-glucosidase in different cell types. Gene (Amst) 1993;127:255-260.
24. Qi X, Leonova T, Grabowski GA: Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase. J Biol Chem 1994;269:16746-16753.
25. Nagiec MM, Wells GB, Lester RL, Dickson RC: A suppressor gene that enables Saccharomyces cerevisiae to grow without making sphingolipids encodes a protein that resembles an Escherichia coli fatty acyltransferase. J Biol Chem 1993;268:22156-22163.
26. Tybulewicz VL, Tremblay ML, LaMarca ME, et al.: Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene. Nature (Lond) 1992;357:407-410.
27. Holleran WM: Lipid modulators of epidermal proliferation and differentiation. Adv Lipid Res 1991;24:119-139.
28. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M: TNF activates NF-KB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992;71:765-776.
29. Andrieu N, Salvayre R, Levade T: Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem J 1994;303:341-345.
30. Hannun YA, Loomis CR, Merrill AH Jr, Bell RM: Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 1986;261:12604-12609.
31. Hannun YA, Bell RM: Regulation of protein kinase C by sphingosine and lysosphingolipids. Clin Chim Acta 1989;185:333-345.
32. Oishi K, Zheng B, Kuo JF: Inhibition of Na,K-ATPase and sodium pump by protein kinase C regulators sphingosine, lysophosphatidylcholine, and oleic acid. J Biol Chem 1990;265:70-75.
33. Kim HS, Lee IH, Jeon YJ, Chung CH, Ha DB: Sphingosine blocks both membrane fusion and calmodulin-dependent phosphorylation of the 100-kDa protein of chick embryonic myoblasts. Exp Cell Res 1993;205: 408-411.
34. Arnold RS, Newton AC: Inhibition of the insulin receptor tyrosine kinase by sphingosine. Biochemistry 1991; 30:7747-7754.
35. Johnson JE, Kalmar GB, Sohal PS, Walkey CJ, Yamashita S, Cornell RB: Comparison of the lipid regulation of yeast and rat CTP: Phosphocholine cytidylyltransferase expressed in COS cells. Biochem J 1992; 285:815-820.
36. Wilson E, Wang E, Mullins RE, Liotta DC, Lambeth JD, Merrill AH: Modulation of the free sphingosine levels in human neutrophils by phorbol esters and other factors. J Biol Chem 1988;263:9304-9309.
37. Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH Jr: Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem 1991;266:14486-14490.
38. Spiegel S, Olivera A, Carlson RO: The role of sphingosine in cell growth regulation and transmembrane signaling. Adv Lipid Res 1993;25:105-129.
39. Zhang H, Desai NN, Olivera A, Seki T, Brooker G, Spiefel S: Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Biol Chem 1990;265: 76-81.
40. Desai NN, Spiegel S: Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines. Biochem Biophys Res Commun 1991;181:361-366.
41. Ghosh TK, Bian J, Gill DL: Intracellular calcium release mediated by sphingosine derivative generated in cells. Science (Wash D C) 1990;248:1653-1656.
42. Yule DI, Wu D, Essington TE, Shayman JA, Williams JA: Sphingosine metabolism induces Ca2+ oscillations in rat pancreatic acinar cells. J Biol Chem 1993;268: 12353-12358.
43. Schroeder JJ, Crane HM, Xia J, Liotta DC, Merrill AH Jr: Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. J Biol Chem 1994;269:3475-3481.
44. Nakamura T, Abe A, Balazovich K, et al.: Ceramide regulates oxidant release in adherent human neutrophils. J Biol Chem 1994;269:18384-18389.
45. Sakane F, Yamada K, Kanoh H: Different effects of sphingosine, R59022 and anionic amphophiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol. FEBS (Fed Eur Biochem Soc) Lett 1989;255:409-413.
46. Mullmann TJ, Siegel MI, Egan RW, Billah MM: Sphingosine inhibits phosphatidate phosphohydrolase in human neutrophils by a protein kinase C-independent mechanism. J Biol Chem 1991;266:2013-2016.
47. Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH: Inhibition of sphingolipid biosynthesis by fumonisins. J Biol Chem 1991;266:14486-14490.
48. Wang E, Ross PF, Wilson TM, Riley RT, Merrill AH Jr: Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J Nutr 1992;122:1706-1716.
49. Schroeder JJ, Crane HM, Xia J, Liotta DC, Merrill AH Jr: Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. J Biol Chem 1994;269:3475-3481.
50. Igarashi Y, Hakomori S: Enzymatic synthesis of N,N-dimethyl-sphingosine: Demonstration of the sphingosine: N-methyltransferase in mouse brain. Biochem Biophys Res Commun 1989;164:1411-1416.
51. 3 in HL-60 cells. J Biol Chem 1989;264:19076-19080.
52. Dressler KA, Mathias S, Kolesnick RN: Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science (Wash D C) 1992;255:1715-1718.
53. 2 production and sphingomyelin metabolism. J Biol Chem 1992;267:20044-20050.
54. Kim MY, Linardic C, Obeid L, Hannun Y: Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor a and γ-interferon. J Biol Chem 1991;266:484-489.
55. 2 and lactoferrin release in adherent human neutrophils. J Biol Chem 1994;269: 8063-8068.
56. Niculescu F, Rus H, Shin S, Lang T, Shin ML: Generation of diacylglycerol and ceramide during homologous complement activation. J Immunol 1993;150:214-224.
57. Chatterjee S, Ghosh N: Neutral sphingomyelinase from human urine. Purification and preparation of monospecific antibodies. J Biol Chem 1989;264:12554-12561.
58. Ghosh P, Chatterjee S: Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells. J Biol Chem 1987;262:12550-12556.
59. Jayadev S, Liu B, Bielawska AE, et al.: Role for ceramide in cell cycle arrest. J Biol Chem 1995;270:2047-2052.
60. Obeid LM, Linardic CM, Karolak LA, Hannun YA: Programmed cell death induced by ceramide. Science (Wash D C) 1993;259:1769-1771.
61. Cifone MG, De Maria R, Roncaioli P, et al.: Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1994;180:1547-1552.
62. Jäättela M, Benedict M, Tewari M, et al.: Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 1995;10:2297-2305.
63. Bremer EG, Schlessinger J, Hakomori S-i: Ganglioside-mediated modulation of cell growth. J Biol Chem 1986;261:2434-2440.
64. Shayman JA, Mahdiyoun S, Deshmukh G, et al.: Glucosphingolipid dependence of hormone-stimulated inositol triphosphate formation. J Biol Chem 1990;265: 12135-12138.
65. Brown DA, Rose JK: Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 1992;68:533-544.
66. Chang W-J, Ying Y, Rothberg KG, et al.: Purification and characterization of smooth muscle cell caveolae. J Cell Biol 1994;126:127-138.
67. Faucher M, Girones N, Hannun YA, Bell RM, Davis RJ: Regulation of the epidermal growth factor receptor phosphorylation state by sphingosine in A431 human epidermoid carcinoma cells. J Biol Chem 1988;263: 5319-5327.
68. Countaway JL, Northwood IC, Davis RJ: Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669*. J Biol Chem 1989;264:10828-10835.
69. Goldkorn T, Dressler KA, Muindi J, et al.: Ceramide stimulated epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. J Biol Chem 1991;266:16092-16097.
70. Liu J, Mathias S, Yang Z, Kolesnick RN: Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem 1994;269:3047-3052.
71. Derijard B, Hibi M, Wu IH, et al.: JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76:1025-1037.
72. Kyriakis JM, Banerjee P, Nikolakaki E, et al.: The stress-activated protein kinase subfamily of c-Jun kinases. Nature (Lond) 1994;369:156-160.
73. Gupta S, Campbell D, Derijard B, Davis RJ: Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science (Wash D C) 1995;267:389-393.
74. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T: The stress-activated protein kinases are major c-Jun ammo-terminal kinases activated by ischemia and reperfusion. J Biol Chem 1994; 269:26546-26551.
75. Bird TA, Kyriakis JM, Tyshler L, Gayle M, Milne A, Virca GD: Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, raf-1, and MAP kinase kinase. J Biol Chem 1994;269: 31836-31844.
76. Seufferlein T, Rozengurt E: Sphingosine induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal adhesion contact assembly in Swiss 3T3 cells. J Biol Chem 1994;269: 27610-27617.
77. Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA: Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 1993;268:15523-15530.
78. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M: TNF activates NF-KB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 1992;71:765-776.
79. Yang Z, Costanzo M, Golde DW, Kolesnick RN: Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor kappa B translocation in intact HL-60 cells. J Biol Chem 1993;268:20520-20523.
80. Betts JC, Agranoff AB, Nabel GJ, Shayman JA: Dissociation of endogenous cellular ceramide from NF-κB activation. J Biol Chem 1994;269:8455-8458.
81. Dbaibo GS, Obeid LM, Hannun YA: Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B. J Biol Chem 1993;268:17762-17766.
82. cdc2: In vivo veritas? Cell 1990;61:549-551.
83. cdc2 protein kinase in vertebrates. EMBO (Eur Mol Biol Organ) J 1991;10:3321-3329.
84. cdc2 exclusively on Tyr15. EMBO (Eur Mol Biol Organ J 1993;12:75-85.
85. Lee TH, Solomon MJ, Mumby MC, Kirschner MW: INH, a negative regulator of MPF, is a form of protein phosphatase 2a. Cell 1991;64:415-423.
86. Lorca T, Labbé J, Devault A, et al.: Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. EMBO (Eur Mol Biol Organ) J 1992;11:2381-2390.
87. Goldkorn T, Dressler KA, Muindi J, et al.: 1991. Ceramide stimulated epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. J Biol Chem 1991;266:16092-16097.
88. Chao R, Khan W, Hannun YA: Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. J Biol Chem 1992;267:23459-23462.
89. Hannun YA, Obeid LM, Wolff RA: The novel second messenger ceramide: Identification, mechanism of action, and cellular activity. Adv Lipid Res 1993;25: 43-64.
90. Rani CS, Abe A, Chang Y, Saltiel AR, Radin NS, Shayman JA: Cell cycle arrest induced by an inhibitor of glucosylceramide synthase-correlation with cyclin-dependent kinases. J Biol Chem 1995;270:2859-2867.
91. Dbaibo GS, Pushkareva MY, Jayadev S, et al.: Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci U S A 1995;92:1347-1351.
92. Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA: Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 1993;268:15523-15530.
93. Petersen J, Ross J, Rabkin R: Effect of insulin therapy on established diabetic nephropathy in rats. Diabetes 1988;37:1346-1350.
94. Tuttle KR, Bruton JL, Peruser MC, Lancaster JL, Kopp DT, DeFronzo RA: Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991;324:1626-1632.
95. Bucala R, Cerami A: Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 1992;23:1-34.
96. Craven PA, Davidson CM, DeRubertis FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 1990; 39:667-674.
97. Beyer-Mears A, Ku L, Cohen MP: Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Diabetes 1984;33:604-607.
98. Tilton RG, Baier LD, Harlow JE, Smith SR, Ostrow E, Williamson JR: Diabetes-induced glomerular dysfunction: Links to a more reduced cytosolic ratio of NADH/ NAD+. Kidney Int 1992;41:778-788.
99. Steer KA, Sochor M, Gonzalez AM, McLean P: Regulation of pathways of glucose metabolism in kidney. Specific linking of pentose phosphate activity with kidney growth in experimental diabetes and unilateral nephrectomy. FEBS (Fed Eur Biochem Soc) Lett 1982; 150:494-498.
100. Needleman P, Passonneau JV, Lowry OH: Distribution of glucose and related metabolites in rat kidney. Am J Physiol 1968;215:655-659.
101. Sochor M, Baquer NZ, McLean P: Regulation of pathways of glucose metabolism in kidney. The effect of experimental diabetes on the activity of the pentose phosphate pathway and glucuronate-xylulose pathway. Arch Biochem Biophys 198;1979:632-646.
102. Steer KA, Sochor M, McLean P: Renal hypertrophy in experimental diabetes. Changes in pentose phosphate pathway activity. Diabetes 1985;34:485-490.
103. Cortes P, Levin NW, Dumler F, Rubenstein AH, Verghese CP, Venkatachalam KK: Uridine triphosphate and RNA synthesis during diabetes-induced renal growth. Am J Physiol 1980;238:E349-357.
104. Zador IZ, Deshmukh GD, Kunkel R, Johnson K, Radin NS, Shayman JA: A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus. J Clin Invest 1993;91:797-803.
105. El-Khatib M, Radin NS, Shayman JA: Glycosphingolipid synthesis and proliferation is a renal cell line grown in high glucose. Am J Physiol 1996, in press.
106. Deshmukh DG, Radin NS, Gattone VH, Shayman JA: Glycosphingolipid abnormalities in the polycystic (cpk/ cpk) mouse. J Lipid Res 1994;35:1611-1618.